The Journal of Infectious Diseases · 2002 · 172 citations · 27 references
Veterinary MedicineImmunologyInfectious DiseasesImmunology Of Infectious DiseasesInnate ImmunitySepsisAntibody-mediated ProtectionBacterial InfectionsBacterial PathogenesisBacterial Secretion SystemsBacterial ToxinsSepsis PathophysiologyAntibody-mediated Bacterial ProtectionEpitope SpecificityInnate Immune ProtectionMonoclonal Antibody CharacterizationPolyclonal AntibodiesProtective Antigen IdentificationToxin Secretion SystemsVirulence Factor Expression
Pseudomonas aeruginosa is a gram-negative pathogen causing life-threatening infections. Lung injury and the development of sepsis depend largely on the expression of type III secretion system (TTSS) virulence. TTSS functions as a molecular syringe to deliver toxins directly to the cytosol of cells, inhibit innate immune mechanisms, and prevent bacterial clearance. Polyclonal antibodies that bind to PcrV of P. aeruginosa inhibit the delivery of type III toxins and enhance the clearance of bacteria during acute lung infections. PcrV is a homologue of LcrV, a protective antigen in the Yersinia TTSS and an integral component of TTSS. In this study, a murine monoclonal antibody (MAb) to PcrV was generated: MAb 166, which is protective against P. aeruginosa when coinstilled with the bacterial inoculum or intraperitoneally transferred to mice. Fab fragments from MAb 166 prevent sepsis and death. The epitope bound by MAb 166 was mapped to the carboxyl-terminus of PcrV.
27
Michael Sheets, Peter Amersdorfer, Ricarda Finnern et al. · Proceedings of the National Academy of Sciences · 1998 · 440 citations
Pharmacy, Biochemistry, Immunology +17
Arup Roy‐Burman, Richard H. Savel, Sara Racine et al. · The Journal of Infectious Diseases · 2001 · 439 citations · Full text